UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000026800
Receipt No. R000030766
Scientific Title Clinical study of contrast-enhanced mammography on pre-operative diagnosis of breast cancer
Date of disclosure of the study information 2017/04/06
Last modified on 2019/07/31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical study of contrast-enhanced mammography on pre-operative diagnosis of breast cancer
Acronym Clinical study of contrast-enhanced mammography
Scientific Title Clinical study of contrast-enhanced mammography on pre-operative diagnosis of breast cancer
Scientific Title:Acronym Clinical study of contrast-enhanced mammography
Region
Japan

Condition
Condition Breast cancer
Classification by specialty
Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To compare contrast-enhanced mammography and breast enhanced MRI with histopathological results.
To survey patient's satisfaction using questionnaire.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To compare contrast-enhanced mammography and breast enhanced MRI in the size estimation of preoperative breast cancers using postoperative histology.
Key secondary outcomes Relationship between detectability and background density of the breast.
Relationship between detectability and the experimental level of radiologist.
Sore of questionnaire on patient's satisfaction.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Female
Key inclusion criteria 1.The patients who have histologically proven breast cancer and a plan for operation of the breast cancer in our hospital.
2.The patients who had been taken breast enhanced MRI in our hospital.
3.The patients who can make a position on examination of mammography.
4.The patients who consent in participation in this study with the written consent form.
Key exclusion criteria 1.The patient who has the surgical history on examination area of the chest-wall.
2.The patients who can not take MRI with some medical reasons.
3.The patients who had taken neo-adjuvant chemotherapy.
4.The patients during pregnancy or with possibility.
5.The patients with the medical reasons of contraindication or notice for using iodine contrast agent.
6.The patients with positive inked margin breast cancer in postoperative histology.
7.The patients who are not suitable for participation in this study according to doctor's opinion.
Target sample size 50

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Miwako Nozaki
Organization Dokkyo Medical University Koshigaya Hospital
Division name Radiology
Zip code
Address 2-1-50 Minamikoshigaya Koshigaya,Saitama
TEL 048-965-1111
Email miwako@dokkyomed.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Emi Sanjo
Organization Dokkyo Medical University Koshigaya Hospital
Division name Radiology
Zip code
Address 2-1-50 Minamikoshigaya Koshigaya,Saitama
TEL 048-965-1111
Homepage URL
Email esan369@yahoo.co.jp

Sponsor
Institute Dokkyo Medical University Koshigaya Hospital
Institute
Department

Funding Source
Organization Self-funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 04 Month 06 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 03 Month 01 Day
Date of IRB
2017 Year 03 Month 13 Day
Anticipated trial start date
2017 Year 04 Month 12 Day
Last follow-up date
2018 Year 12 Month 18 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information None

Management information
Registered date
2017 Year 03 Month 31 Day
Last modified on
2019 Year 07 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030766

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.